These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 30230765)

  • 1. ASSESSING THE EFFICACY OF NITAZOXANIDE IN TREATMENT OF CRYPTOSPORIDIOSIS USING PCR EXAMINATION.
    Abaza BE; Hamza RS; Farag TI; Abdel-Hamid MA; Moustafa RA
    J Egypt Soc Parasitol; 2016 Dec; 46(3):683-692. PubMed ID: 30230765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of nitazoxanide on cryptosporidiosis in experimentally infected neonatal dairy calves.
    Ollivett TL; Nydam DV; Bowman DD; Zambriski JA; Bellosa ML; Linden TC; Divers TJ
    J Dairy Sci; 2009 Apr; 92(4):1643-8. PubMed ID: 19307646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial.
    Amadi B; Mwiya M; Musuku J; Watuka A; Sianongo S; Ayoub A; Kelly P
    Lancet; 2002 Nov; 360(9343):1375-80. PubMed ID: 12423984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of Cryptosporidium parvum infection in immunocompetent and immunocompromised mice and its role in triggering intestinal dysplasia.
    Abdou AG; Harba NM; Afifi AF; Elnaidany NF
    Int J Infect Dis; 2013 Aug; 17(8):e593-600. PubMed ID: 23291034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The therapeutic efficacy of azithromycin and nitazoxanide in the acute pig model of Cryptosporidium hominis.
    Lee S; Harwood M; Girouard D; Meyers MJ; Campbell MA; Beamer G; Tzipori S
    PLoS One; 2017; 12(10):e0185906. PubMed ID: 28973041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of Nitazoxanide.
    Rossignol JF; Ayoub A; Ayers MS
    J Infect Dis; 2001 Jul; 184(1):103-6. PubMed ID: 11398117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic and therapeutic efficacy of nitazoxanide against Cryptosporidium parvum in experimentally challenged neonatal calves.
    Schnyder M; Kohler L; Hemphill A; Deplazes P
    Vet Parasitol; 2009 Mar; 160(1-2):149-54. PubMed ID: 19062195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunomodulatory activity of secnidazole-nitazoxanide in a murine cryptosporidiosis model.
    Madbouly N; El Amir A; Abdel Kader A; Rabee I; Farid A
    J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33625354
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of a Cryptosporidium hominis outbreak in a day-care center.
    Vandenberg O; Robberecht F; Dauby N; Moens C; Talabani H; Dupont E; Menotti J; van Gool T; Levy J
    Pediatr Infect Dis J; 2012 Jan; 31(1):10-5. PubMed ID: 22094626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A double-'blind' placebo-controlled study of nitazoxanide in the treatment of cryptosporidial diarrhoea in AIDS patients in Mexico.
    Rossignol JF; Hidalgo H; Feregrino M; Higuera F; Gomez WH; Romero JL; Padierna J; Geyne A; Ayers MS
    Trans R Soc Trop Med Hyg; 1998; 92(6):663-6. PubMed ID: 10326116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High dose prolonged treatment with nitazoxanide is not effective for cryptosporidiosis in HIV positive Zambian children: a randomised controlled trial.
    Amadi B; Mwiya M; Sianongo S; Payne L; Watuka A; Katubulushi M; Kelly P
    BMC Infect Dis; 2009 Dec; 9():195. PubMed ID: 19954529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of nitazoxanide against experimental cryptosporidiosis in goat neonates.
    Viel H; Rocques H; Martin J; Chartier C
    Parasitol Res; 2007 Dec; 102(1):163-6. PubMed ID: 17874133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitazoxanide in the treatment of acquired immune deficiency syndrome-related cryptosporidiosis: results of the United States compassionate use program in 365 patients.
    Rossignol JF
    Aliment Pharmacol Ther; 2006 Sep; 24(5):887-94. PubMed ID: 16918894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use-case scenarios for an anti-Cryptosporidium therapeutic.
    Ashigbie PG; Shepherd S; Steiner KL; Amadi B; Aziz N; Manjunatha UH; Spector JM; Diagana TT; Kelly P
    PLoS Negl Trop Dis; 2021 Mar; 15(3):e0009057. PubMed ID: 33705395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of chitosan nanoparticles in improving the efficacy of nitazoxanide on cryptosporidiosis in immunosuppressed and immunocompetent murine models.
    Moawad HSF; Hegab MHAE; Badawey MSR; Ashoush SE; Ibrahim SM; Ali AAES
    J Parasit Dis; 2021 Sep; 45(3):606-619. PubMed ID: 34475640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of nitazoxanide against Cryptosporidium parvum in cell culture and in animal models.
    Theodos CM; Griffiths JK; D'Onfro J; Fairfield A; Tzipori S
    Antimicrob Agents Chemother; 1998 Aug; 42(8):1959-65. PubMed ID: 9687390
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryptosporidiosis gets a new treatment.
    Bornhoeft MA
    Body Posit; 1998 Mar; 11(3):13. PubMed ID: 11365247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atorvastatin repurposing for the treatment of cryptosporidiosis in experimentally immunosuppressed mice.
    Madbouly Taha N; Salah A Yousof HA; El-Sayed SH; Younis AI; Ismail Negm MS
    Exp Parasitol; 2017 Oct; 181():57-69. PubMed ID: 28764965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryptosporidiosis after treatment with fingolimod: a case report and pharmacovigilance review.
    Martinot M; Abou-Bacar A; Lamothe M; Tebacher MA; Zadeh MM; Dalle F; Favennec L; Costa D; Brunet J; Sellal F
    BMC Infect Dis; 2020 Mar; 20(1):257. PubMed ID: 32228484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative study between the effect of nitazoxanide and paromomycine in treatment of cryptosporidiosis in hospitalized children.
    Hussien SM; Abdella OH; Abu-Hashim AH; Aboshiesha GA; Taha MA; El-Shemy AS; El-Bader MM
    J Egypt Soc Parasitol; 2013 Aug; 43(2):463-70. PubMed ID: 24260825
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.